secwatch.observer — SEC 8-K summary
======================================

Issuer:     Canopy Growth Corp (CGC)
CIK:        0001737927
Form:       8-K
Filed at:   2024-02-09T23:59:59+00:00
Accession:  0000950170-24-013050
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Canopy Growth Q3 FY2024 revenue $78.5M; adjusted EBITDA loss narrows 82% to $9M
-------------------------------------------------------------------------------

- Net revenue $78.5M, down 7% YoY; net loss from continuing operations $230.3M.
- Adjusted EBITDA loss $9.0M, improving 82% from $50M loss in Q3 FY2023.
- Canada medical cannabis revenue record $15.6M (+11% YoY); Canada B2B adult-use revenue up 9%.
- Cash and short-term investments $186M; debt reduced by $69M during quarter.
- Canopy USA special meeting set for April 12, 2024; board appoints two new directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737927/000095017024013050/0000950170-24-013050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737927/000095017024013050/cgc-20240209.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-013050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer